UK stock markets closed lower on Friday, easing back after a record-breaking October rally as investors adopted a more cautious stance ahead of the Bank of England’s monetary policy decision and the Government’s Budget this month.
UK stock markets closed lower on Friday, easing back after a record-breaking October rally as investors adopted a more cautious stance ahead of the Bank of England’s monetary policy decision and the Government’s Budget this month.
Yesterday: ACG Metals (ACG) targets copper, zinc output by mid-2026, CEO says | Hotter Commodities. ACG Metals expects to begin to produce copper and zinc concentrates in mid-2026, marking a shift from
Hemogenyx Pharmaceuticals (LON: HEMO) has received clearance from its independent Data Safety Monitoring Board (DSMB) to proceed to the next adult dose level in its Phase I clinical trial of
The Times: Specialist small business lender Shawbrook has announced plans to float on the London Stock Exchange — providing a further boost to the London market.
The broader market was quiet for small-cap stocks this week. The AIM All-Share index rose slightly, gaining fewer than two points to close at 775.68. This was a marginal outperformance
The Telegraph: Ocado’s grand ambitions threaten to end in disaster
Hemogenyx Pharmaceuticals Signs Letter of Intent with Cellin Technologies to Advance Commercialization of HG-CT-1 CAR-T Therapy in Estonia First Potential Near-Term Revenue Opportunity
London’s blue-chip FTSE 100 index closed 11 points lower at 9,216 on Friday, leaving it down around 0.7% for the week. The FTSE 250 mid-cap index shed 0.6%, with Raspberry
Yesterday, Empire Metals Limited (EEE), the resource exploration and development company, said it would like to respond to recent sharp decline in the Company’s share price and would like to clarify that
Hemogenyx Pharmaceuticals has announced encouraging progress in its Phase I clinical trial of HG-CT-1, a CAR-T cell therapy targeting relapsed/refractory acute myeloid leukemia (AML) in adults.
BBC: Spurs ‘not for sale’ as owner rejects buyout interest
Bluebird Mining Ventures (BMV), a gold development company, has executed a £2 million Investment Agreement with Skylake Management LLP, an investment vehicle domiciled in United Kingdom. £2 million by way of